MIT Koch Institute
November 21, 2019
New startup Immunitas Therapeutics combines immunology and genetic targeting to stop tumors with a platform incorporating Bridge Project research by Aviv Regev, Mario Suvà, Dane Wittrup, and Kai Wucherpfennig.
Sunflower Therapeutics will develop the Love lab’s nimble technology to dramatically reduce the time and cost to develop and manufacture biologics for patients around the world, from orphan diseases to areas without healthcare infrastructure.